- US Unemployment Claims Fall to 222000, Lowest in 44 YearsU.S. News & World Report
- Fewest Jobless Claims Since 1973 Show Firm US Job MarketBloomberg
- A key measure of the jobs market just fell to its lowest level since 1973Business Insider
Business
FDA Approval Of Gilead CAR-T Therapy Will Move The Needle
- FDA Approval Of Gilead CAR-T Therapy Will Move The NeedleSeeking Alpha
- These 5 Top Stocks Are Moving Late On News: S&P 500 FuturesInvestor’s Business Daily
- A cancer treatment that’s part of ‘a big new field of medicine’ just got approvedBusiness Insider
- UPDATED: FDA follows through with a groundbreaking OK for Yescarta, Gilead’s new CAR-T breakthroughEndpoints News
- Cutting-edge immunotherapy treatment approved for another deadly cancerWashington Post
US FDA approves Gilead cancer gene therapy; price set at $373000
- US FDA approves Gilead cancer gene therapy; price set at $373000Reuters
- These 5 Top Stocks Are Moving Late On News: S&P 500 FuturesInvestor’s Business Daily
- Move over, Novartis: Kite and Gilead break into CAR-T market with early axi-cel nodFiercePharma
- UPDATED: FDA follows through with a groundbreaking OK for Yescarta, Gilead’s new CAR-T breakthroughEndpoints News
- FDA Approves Second Gene-Altering Treatment for CancerNew York Times
Gilead cancer immunotherapy wins US approval with $373000 price
- Gilead cancer immunotherapy wins US approval with $373000 priceNasdaq
- The FDA just approved a revolutionary gene-modification treatmentQuartz
- Kite Nabs First Adult CAR-T Approval With Notable Uptick Of CuresXconomy
- UPDATED: FDA follows through with a groundbreaking OK for Yescarta, Gilead’s new CAR-T breakthroughEndpoints News
- Cutting-edge immunotherapy treatment approved for another deadly cancerWashington Post